Eslicarbazepine Acetate
- 醋酸艾司利卡西平;BIA 2-093
货号: abs816083
货号-规格 | 货期 | 价格 | 数量 |
abs816083-10mg | 1-2周 | ¥552.00 | - + |
abs816083-20mg | 1-2周 | ¥964.00 | - + |
abs816083-100mg | 1-2周 | ¥2048.00 | - + |

产品描述 | ||
描述 | Eslicarbazepine acetate (ESL) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy. | |
纯度 | 99% | |
储存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. | |
基本信息 | ||
别名 | 醋酸艾司利卡西平;BIA 2-093 | |
外观 | 白色固体 | |
可溶性/溶解性 | DMSO : 55 mg/mL (185.6 mM) Ethanol : 9 mg/mL (30.4 mM) | |
生物活性 | ||
靶点 | Beta-secretase | |
In vivo(体内研究) | Eslicarbazepine acetate is an antiepileptic drug. It is a prodrug which is activated to eslicarbazepine (S-licarbazepine), an active metabolite of oxcarbazepine. Eslicarbazepine acetate is a prodrug for (S)-(+)-licarbazepine, the major active metabolite of oxcarbazepine. Its mechanism of action is therefore identical to that of oxcarbazepine. Eslicarbazepine acetate may not produce as high peak levels of (S)-(+)-licarbazepine immediately after dosing as does oxcarbazepine which could theoretically improve tolerability. | |
参考文献 | ||
参考文献 | ||
温馨提示:本产品仅作科研实验使用,不支持临床等研究 |
- 实验方法 实验条件
共 0 张,还能上传 8 张 提交
- 提示: 尊敬的客户您好,如果您对我们的产品有什么疑问或想要了解的,可以点击“我要咨询”按钮填写您的疑问。
提交不成功?请联系info@absin.cn。
促销资讯 更多
订购信息
您可以从我们的授权经销商处购买absin产品或获得技术支持。若要查看您所在地区的经销商,请从以下的下拉列表中选择。